Subtopic Deep Dive
cBioPortal Cancer Genomics Analysis
Research Guide
What is cBioPortal Cancer Genomics Analysis?
cBioPortal Cancer Genomics Analysis uses the cBioPortal platform for visualizing and querying multi-omic cancer datasets from TCGA and ICGC to identify driver mutations and correlate genomics with clinical outcomes.
cBioPortal enables real-time pan-cancer analysis across 50,000+ genomes. Researchers query somatic mutations, copy number alterations, and expression data interactively (Weinstein et al., 2013). Over 20 TCGA marker papers leverage this resource (Colaprico et al., 2015).
Why It Matters
cBioPortal powers hypothesis generation for precision oncology by democratizing access to TCGA/ICGC cohorts, enabling discovery of oncogenic signatures (Ciriello et al., 2013; 1411 citations). Pereira et al. (2016; 1745 citations) refined breast cancer landscapes using portal data, identifying therapeutic targets. Witkiewicz et al. (2015; 1135 citations) defined pancreatic cancer diversity via whole-exome sequencing visualized in cBioPortal, guiding clinical trials.
Key Research Challenges
Variant Calling Accuracy
Next-generation sequencing in cancer requires precise SNV/MNV detection amid tumor heterogeneity. VarDict addresses this for DNA/RNA data but struggles with low-frequency variants (Lai et al., 2016; 1019 citations). Standards for reporting remain inconsistent (Li et al., 2016; 1882 citations).
Pan-Cancer Driver Identification
Distinguishing drivers from passengers across 33 tumor types demands robust statistical models. TCGA Pan-Cancer project revealed widespread lineage diversity (Chang et al., 2015; 808 citations). Real-time queries amplify false positives in large cohorts (Weinstein et al., 2013).
Clinical Outcome Correlation
Linking multi-omic profiles to survival data faces confounding from cohort biases. Single-cell profiling adds granularity but increases complexity (Chung et al., 2017; 1019 citations). Integrative tools like TCGAbiolinks help but require expertise (Colaprico et al., 2015).
Essential Papers
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein, Jun Li, Gordon B. Mills et al. · 2013 · Nature Genetics · 9.0K citations
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico, Tiago C. Silva, Catharina Olsen et al. · 2015 · Nucleic Acids Research · 4.2K citations
The Cancer Genome Atlas (TCGA) research network has made public a large collection of clinical and molecular phenotypes of more than 10 000 tumor patients across 33 different tumor types. Using thi...
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak, Patrycja Czerwińska, Maciej Wiznerowicz · 2015 · Współczesna Onkologia · 3.4K citations
The Cancer Genome Atlas (TCGA) is a public funded project that aims to catalogue and discover major cancer-causing genomic alterations to create a comprehensive "atlas" of cancer genomic profiles. ...
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Marilyn M. Li, Michael Datto, Eric J. Duncavage et al. · 2016 · Journal of Molecular Diagnostics · 1.9K citations
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
Bernard Pereira, Suet‐Feung Chin, Oscar M. Rueda et al. · 2016 · Nature Communications · 1.7K citations
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello, Martin L. Miller, Bülent Arman Aksoy et al. · 2013 · Nature Genetics · 1.4K citations
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz, Elizabeth A. McMillan, Uthra Balaji et al. · 2015 · Nature Communications · 1.1K citations
Abstract Pancreatic ductal adenocarcinoma (PDA) has a dismal prognosis and insights into both disease etiology and targeted intervention are needed. A total of 109 micro-dissected PDA cases were su...
Reading Guide
Foundational Papers
Start with Weinstein et al. (2013; 8983 citations) for Pan-Cancer framework, then Ciriello et al. (2013; 1411 citations) for oncogenic signatures to grasp cBioPortal's core utility.
Recent Advances
Study Pereira et al. (2016; 1745 citations) for breast cancer refinement and Lai et al. (2016; 1019 citations) for VarDict integration with portal data.
Core Methods
OncoPrint visualization, Mutation Mapper, survival plots; R tools via TCGAbiolinks (Colaprico et al., 2015); variant calling with VarDict (Lai et al., 2016).
How PapersFlow Helps You Research cBioPortal Cancer Genomics Analysis
Discover & Search
Research Agent uses searchPapers and citationGraph to map TCGA Pan-Cancer literature from Weinstein et al. (2013; 8983 citations), then exaSearch for cBioPortal-specific queries and findSimilarPapers for oncogenic signatures like Ciriello et al. (2013).
Analyze & Verify
Analysis Agent applies readPaperContent on Colaprico et al. (2015) TCGAbiolinks methods, verifies mutation correlations via runPythonAnalysis (pandas survival plots), and uses verifyResponse (CoVe) with GRADE grading for driver evidence strength in pan-cancer cohorts.
Synthesize & Write
Synthesis Agent detects gaps in variant standards (Li et al., 2016), flags contradictions in driver landscapes; Writing Agent uses latexEditText, latexSyncCitations for TCGA reports, and latexCompile with exportMermaid for mutation pathway diagrams.
Use Cases
"Reanalyze TCGA breast cancer mutations with survival stats using cBioPortal data."
Research Agent → searchPapers('TCGA breast cancer cBioPortal') → Analysis Agent → runPythonAnalysis(pandas Cox regression on Pereira et al. 2016 data) → matplotlib survival curves output.
"Draft LaTeX review of pan-cancer drivers from cBioPortal."
Synthesis Agent → gap detection(Weinstein 2013 + Ciriello 2013) → Writing Agent → latexEditText + latexSyncCitations(8983-cite paper) → latexCompile → PDF with oncoprint figure.
"Find GitHub repos for VarDict cancer variant calling linked to cBioPortal."
Research Agent → paperExtractUrls(Lai 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable VarDict pipeline for TCGA data.
Automated Workflows
Deep Research workflow scans 50+ TCGA papers via citationGraph from Weinstein et al. (2013), producing structured cBioPortal review with GRADE scores. DeepScan applies 7-step CoVe to verify pan-cancer drivers (Ciriello et al., 2013), checkpointing mutation stats. Theorizer generates hypotheses on POLE mutations from portal queries (Hussein et al., 2014).
Frequently Asked Questions
What is cBioPortal Cancer Genomics Analysis?
cBioPortal is an open-access platform for exploring TCGA/ICGC multi-omic data, visualizing mutations and clinical correlations across 50,000+ samples (Weinstein et al., 2013).
What methods power cBioPortal analyses?
Interactive queries of somatic mutations, CNA, and RNA-seq via OncoPrint and Mutation Mapper; integrates TCGAbiolinks for R-based pipelines (Colaprico et al., 2015).
What are key papers?
Weinstein et al. (2013; 8983 citations) launched Pan-Cancer analysis; Ciriello et al. (2013; 1411 citations) mapped oncogenic signatures; Pereira et al. (2016; 1745 citations) profiled breast cancers.
What open problems exist?
Accurate low-frequency variant calling (Lai et al., 2016), pan-cancer driver validation (Chang et al., 2015), and single-cell integration with outcomes (Chung et al., 2017).
Research Cancer Genomics and Diagnostics with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching cBioPortal Cancer Genomics Analysis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Cancer Genomics and Diagnostics Research Guide